With impressive speed Garcia-Cremades et al1 have modelled the association between hydroxychloroquine HCQ and viral load merging literature in vitro data and data from a recently published clinical study which as of April 11 2020 is under investigation by the publisher2. Whilst the authors are to be commended on bringing quantitative clinical pharmacology insight to this health emergency caution is required on interpreting their results. Quantitative clinical pharmacology input to SARS-CoV-2 therapeutics should be based on robust data.